This extent of CCR5 down-regulation might be sufficient to affect virus infection, since studies with anti-CCR5 antibodies have demonstrated that their exposure to PBMC can drop the mean surface expression of CCR5 from CD4+ T-lymphocytes or U87-CCR5 cell cultures to 19–37% of control. Here, CD4 is linked to viral infectious disease.